Back
Lam Research Vs. Novo Nordisk AS Industry Stock Comparison
Buy
61
LRCX
Lam Research
Last Price:
$76.93
Seasonality Move:
13.28%
Sell
9
NONOF
Novo Nordisk AS
Last Price:
$85.54
Seasonality Move:
8.64%
Buy
61
Lam Research (LRCX)
is a Buy
Is Lam Research a Buy, Sell or Hold?
-
The current Lam Research [LRCX] share price is $77.52. The Score for LRCX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
LRCX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
9
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $83.49. The Score for NONOF is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
LRCX Stock Price Chart
What is Lam Research's stock price today?
-
The Lam Research share price today is $77.52Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LRCX is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $83.49Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
LRCX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 57.33 | Buy |
| Chaikin Money Flow: | -6115154 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.11 - 77.75) | Buy |
| Bollinger Bands (100): | (72.9 - 81.46) | Buy |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.33 | Sell |
| Relative Strength Index (14 RSI): | 28.84 | Sell |
| Chaikin Money Flow: | -3979 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (87.37 - 110.31) | Sell |
| Bollinger Bands (100): | (100 - 129.72) | Sell |
LRCX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.35 | Buy |
| 20-day SMA: | 74.95 | Buy |
| 50-day SMA: | 74.93 | Buy |
| 200-day SMA: | 86.25 | Sell |
| 8-day EMA: | 75.2 | Buy |
| 20-day EMA: | 74.81 | Buy |
| 50-day EMA: | 75.56 | Buy |
| 200-day EMA: | 80.47 | Sell |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 86.05 | Sell |
| 20-day SMA: | 96.21 | Sell |
| 50-day SMA: | 103.01 | Sell |
| 200-day SMA: | 123.85 | Sell |
| 8-day EMA: | 86.84 | Sell |
| 20-day EMA: | 93.21 | Sell |
| 50-day EMA: | 102.18 | Sell |
| 200-day EMA: | 114.99 | Sell |
Lam Research Earnings Growth & LRCX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $26.21 per share, and an increase next year of $0.63 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Lam Research Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||